$398 Million is the total value of ARDSLEY ADVISORY PARTNERS LP's 104 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MBII | MARRONE BIO INNOVATIONS INC | $13,215,000 | -19.5% | 10,323,247 | 0.0% | 3.32% | +50.1% | |
| PGNX | PROGENICS PHARMACEUTICALS INcall | $2,100,000 | -33.0% | 500,000 | 0.0% | 0.53% | +25.1% | |
| UNH | UNITEDHEALTH GROUP INC | $1,495,000 | -6.3% | 6,000 | 0.0% | 0.38% | +74.9% | |
| QTNT | QUOTIENT LTD | $673,000 | -19.0% | 110,000 | 0.0% | 0.17% | +50.9% | |
| FB | FACEBOOK INCput | $655,000 | -20.3% | 5,000 | 0.0% | 0.16% | +48.6% | |
| ATRC | ATRICURE INC | $459,000 | -12.6% | 15,000 | 0.0% | 0.12% | +62.0% | |
| NVTRQ | NUVECTRA CORP | $410,000 | -25.7% | 25,095 | 0.0% | 0.10% | +39.2% | |
| CERS | CERUS CORP | $406,000 | -29.6% | 80,000 | 0.0% | 0.10% | +30.8% | |
| ACER | ACER THERAPEUTICS INC | $402,000 | -34.8% | 20,000 | 0.0% | 0.10% | +21.7% | |
| ALBO | ALBIREO PHARMA INC | $248,000 | -25.5% | 10,100 | 0.0% | 0.06% | +37.8% | |
| AZRX | AZURRX BIOPHARMA INC | $182,000 | -52.8% | 150,000 | 0.0% | 0.05% | -11.5% | |
| CHRS | COHERUS BIOSCIENCES INC | $136,000 | -45.2% | 15,000 | 0.0% | 0.03% | +3.0% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS IN | $89,000 | -49.7% | 35,000 | 0.0% | 0.02% | -8.3% | |
| NEPT | NEPTUNE WELLNESS SOLUTIONS I | $64,000 | -34.0% | 25,000 | 0.0% | 0.02% | +23.1% | |
| ATNM | ACTINIUM PHARMACEUTICALS INC | $31,000 | -47.5% | 80,000 | 0.0% | 0.01% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUNOPTA INC | 42 | Q3 2023 | 12.1% |
| MICROSOFT CORP | 33 | Q3 2023 | 5.7% |
| MARRONE BIO INNOVATIONS INC | 29 | Q2 2022 | 3.9% |
| SERVICENOW INC | 28 | Q3 2023 | 1.9% |
| FORTRESS TRANS INFRST INVS L | 27 | Q3 2022 | 7.6% |
| PROSHARES TR | 26 | Q3 2023 | 6.6% |
| FERROGLOBE PLC | 26 | Q3 2023 | 2.4% |
| HANNON ARMSTRONG SUST INFR C | 25 | Q3 2020 | 5.2% |
| SUNRUN INC | 25 | Q3 2023 | 6.3% |
| JAZZ PHARMACEUTICALS PLC | 24 | Q2 2020 | 8.0% |
View ARDSLEY ADVISORY PARTNERS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Bioceres Crop Solutions Corp. | January 25, 2023 | 1,854,000 | 3.0% |
| CANTALOUPE, INC. | January 25, 2023 | 3,150,000 | 4.4% |
| Stronghold Digital Mining, Inc.Sold out | January 25, 2023 | 0 | 0.0% |
| MARRONE BIO INNOVATIONS INC | February 08, 2022 | 18,335,767 | 10.4% |
| Just Energy Group Inc. | February 12, 2021 | 450,000 | 0.9% |
| SunOpta Inc. | February 12, 2021 | 3,396,514 | 3.8% |
| USA TECHNOLOGIES INC | February 12, 2021 | 3,725,575 | 5.7% |
| AMERICAN SUPERCONDUCTOR CORP /DE/ | January 26, 2018 | 314,377 | 1.5% |
| BioScrip, Inc. | January 26, 2018 | 90,000 | 0.1% |
| APPLIED OPTOELECTRONICS, INC.Sold out | February 14, 2017 | 0 | 0.0% |
View ARDSLEY ADVISORY PARTNERS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-01-25 |
| SC 13G/A | 2023-01-25 |
| SC 13G | 2023-01-25 |
| 13F-HR | 2022-11-14 |
View ARDSLEY ADVISORY PARTNERS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.